Coronavirus disease 19 (COVID-19) is caused by severe acute respiratory coronavirus 2 (SARS-CoV-2). Apart from respiratory manifestations, COVID-19 can affect the nervous system due to its neurotropic features. Neurological manifestations and complications include headache, polyneuropathies, cerebrovascular accidents, seizures, encephalopathy, and demyelinating disease. We describe a case of multiple sclerosis, a demyelinating disease following COVID-19 infection, rarely reported in the literature. A 47-year-old female presented with fatigue, blurry vision, numbness, and signs of upper motor neuron lesions that had occurred three weeks after COVID-19 infection. Magnetic resonance imaging of the brain revealed demyelinating lesions in the periventricular area of both hemispheres, suggesting a demyelinating disease. A provisional diagnosis of multiple sclerosis was made. Her condition improved after the commencement of methylprednisolone.
【저자키워드】 COVID-19, SARS-CoV-2, multiple sclerosis, Demyelinating diseases, post-covid complications, 【초록키워드】 Methylprednisolone, fatigue, Diagnosis, headache, Brain, Features, COVID-19 infection, female, nervous system, Complication, Encephalopathy, coronavirus disease 19, disease, manifestation, Seizures, lesion, respiratory manifestations, motor neuron, Affect, neurotropic, cerebrovascular accidents, Respiratory Coronavirus, occurred, caused, include, reported, 【제목키워드】 review, literature, report, Multiple, sclerosis,